Regulatory Show all
June 17 | 2020

Notice to attend the extraordinary general meeting of 2cureX AB (publ)

Read more
June 16 | 2020

2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients

Read more
June 16 | 2020

2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients

Read more
June 9 | 2020

Byte av Certified Adviser till Redeye AB

Read more
June 9 | 2020

Change of Certified Adviser to Redeye AB

Read more
May 29 | 2020

2cureX moves forward with the commercialization of IndiTreat by signing a new distributor agreement in Portugal

Read more
May 29 | 2020

2cureX moves forward with the commercialization of IndiTreat by signing a new distributor agreement in Portugal

Read more
May 28 | 2020

Kommuniké från årsstämma i 2cureX AB (publ)

Read more
May 28 | 2020

Communique from the Annual General Meeting in 2cureX AB (publ)

Read more
May 28 | 2020

2cureX publishes interim report for the first quarter of 2020

Read more
May 28 | 2020

2cureX offentliggör delårsrapport för det första kvartalet 2020

Read more
May 7 | 2020

2cureX publishes the annual report for the fiscal year 2019

Read more
May 7 | 2020

2cureX offentliggör årsredovisning för räkenskapsåret 2019

Read more
April 29 | 2020

2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test

Read more
April 29 | 2020

2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test

Read more
April 28 | 2020

Kallelse till årsstämma i 2cureX AB (publ)

Read more
April 28 | 2020

Notice of annual general meeting of 2cureX AB (publ)

Read more
April 6 | 2020

2cureX i Tyskland får bidrag för att anpassa IndiTreat® för vägledning av immunterapi mot äggstockscancer

Read more